In addition, the above three active ingredients benzoylaconitine, aconitine and ellagic acid were also reported to improve the inflammatory condition of RA, reduce the expression of inflammatory factors such as TNF-α and IL-1β, and have a positive effect on alleviating bone damage [33–35]. Here, IL1B is linked to rheumatoid arthritis.